Skip to main content

Table 1 Baseline characteristics of HIV-1 positive participants treated with first-line ART regiments in Jimma, Ethiopia (n =312)

From: Drug resistance in HIV patients with virological failure or slow virological response to antiretroviral therapy in Ethiopia

 

Women (n =179)

Men (n =86)

Total (n = 265)

Excluded, did not complete 6 months (n =47)

Age, y

31.0 ±8.0

38.0 ±9.0

33.0 ±8.8

32.2

Body mass index (BMI), kg/m2

19.6 ±2.5

19.1 ±1.8

19.4 ±2.3

19.5 ±2.5

CD4 count at enrollment, cells/ul

189 ±113

194 ±113

190.7 ±113

181 ±105

Viral load, log(copies/mL )

4.7 ±1.0

4.6 ±0.9

4.7 ±1.0

4.8 ±0.9

WHO stage

    

Stage I

63 (35.2)

23 (26.7)

86 (32.5)

11 (23.4)

Stage II

47 (26.3)

32 (37.2)

79 (29.8)

12 (25.5)

Stage III

53 (29.6)

26 (30.2)

79 (29.8)

19 (40.4)

Stage IV

16 (8.9)

5 (5.8 )

21 (7.9)

5 (10.6)

ART regimen

    

TDF/3TC/EFV

113 (63.1)

77 (89.5)

190 (71.7)

33 (70.2)

AZT/3TC/EFV

2 (1.1)

1 (1.2)

3 (1.1)

1 (2.1)

TDF/3TC/NVP

27 (15.1)

2 (2.3)

29 (10.9)

3 (5.7)

AZT/3TC/NVP

31 (17.3)

4 (4.7)

35 (13.2)

10 (18.9)

Other*

6 (3.4)

2 (2.3)

8 (3.0)

0 (0.0)

  1. *Other regimen includes mainly D4T and NVP based treatment. Data are mean ±SD or n (%).